"Pediatric Acute Lymphoblastic Leukemia (B-ALL): A Cytogenomic Update"

Pathology Clinical Conference

Wednesday, September 27, 2023 at 12:00 PM

This grand round has already taken place.

Online Streaming
September 27th, 2023
1.00 AMA PRA Category 1 Credit Hours


Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. It affects certain cells in the immune system called B cells and T cells. ALL usually affects B cells in children.

The new classification of B-ALL includes ETV6::RUNX1 like, TCF3::HLF fusion, B-ALL with other defined genetic alterations. Here in we will learn the main cytogenetic abnormalities as well as their prognosis in pediatric B-ALL.

Dates and Times

Start: 9/27/2023 12:00 PM
End: 9/27/2023 1:00 PM


1) To understand the main chromosomal abnormalities in B-ALL

2) To understand the difference between standard risk and high risk in pediatric B-ALL

3) To monitor a patient with B-ALL.


  • Carlos Tirado, PhD
    • "Pediatric Acute Lymphoblastic Leukemia (B-ALL): A Cytogenomic Update"


The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Amy Loughlin
Department: Pathology
Phone: (631) 444-3000
Email: Amy.loughlin@stonybrookmedicine.edu

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222